LEP and metabolic syndrome: One of such models used in metabolic syndrome/diabetes studies is genetically modified mice that highly express defective gene coding for the leptin receptor (Leprdb/db); hence, they develop leptin resistance leading to obesity, hyperinsulinemia, and hyperglycemia [86,87].